Biotech stocks plummet in wake of public health policies that favor humans

OVER 60 MILLION GOT SERVED, Just Over The Border, Wednesday (NNN) — Biotechnology companies banking on a severe swine flu pandemic were shocked this week when US health officials approved four H1N1 vaccines, triggering a selloff in the sector.

The original bacon bra“This is outrageous fiscal irresponsibility from the Democrat Party,” said analyst Brian Adams. “A lot of these companies have basically been trading on pandemic concerns. How can the United States possibly lead in the biotech revolution without serious damage from the pandemic? They’re destroying business value!”

The World Health Organization said it could infect as many as one-third of the world’s population, or 2 billion people. “Most of these are in the Third World, of course. If they got all their drugs cheap — or, God forbid, free — that would cut our gross takings by as much as five percent. Just what the hell do they think they’re doing in there? We’ve spent quite enough time and money on onerous intellectual monopoly laws. That money is our right as creative individuals, as the true creators of objective value!”

Businesses in the US will give the swine flu vaccine to their workers, on an “as needed” basis — those being the ones whose insurance they are paying for. “At least the illegals won’t get health care, so they’ll still be a good breeding ground for new and profitable bugs. Thank God.”

Adams said there was still a chance that H1N1 would mutate, rendering vaccines less effective. “Failing that, we’ll just have to see what we can do to push it along. You didn’t write that down? Good, good.”

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.